You again miss the point. I just checked 10 random companies and they all provide links to their SEC reports. This includes a tiny biotech with only 3 employees. Why is AVXL different? Perhaps incompetence in their IR department?
My original post also highlighted a misleading slide purportedly from their current deck that alludes to non-diluting financing when it's only a tiny part of their financing over the last 2 years. Any comments about that?
Nobody is "weaponizing SEC reports" but your first response to me was "New to investing? Initial swing and miss. Most others here are seasoned investors and understand the basics of trading and accessing filings. Funny." Typical pumper response by attacking the messenger while avoiding 2 valid comments about the company's operations.
Market Data 
Markets 
AI
